Clinical Trial Update: Study of Safety, Tolerability and Pharmacokinetics of Single Oral JTT-251 Doses in Healthy and Type 2 Diabetic Subjects [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety, tolerability and pharmacokinetics of single oral doses of JTT-251 in healthy subjects and in individuals with Type 2 diab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• JTT-251 (JTT-251)

Snippet

Sponsor: Akros Pharma Inc. | Conditions: Diabetes Mellitus | Phase 1 | Status: COMPLETED